Hester Biosciences Ltd — Capital/Financing Update 2019

Sep 27, 2019

==> picture [525 x 97] intentionally omitted <==

27 September 2019

To, To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Bandra - Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code: 524669 Symbol: HESTERBIO

Respected Sir/Madam:

Subject: Intimation of assigned Credit Ratings

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("the Regulations"), we would like to inform that CARE Ratings Limited ('CARE Ratings'), vide it's letter dated 24 September 2019 (received by Company on 27 September 2019), has assigned the followings ratings to the Company:

Credit Facility	Existing Ratings	Revised Ratings	Remark
Long - term Bank Facilities	CARE "A- : Stable" (Single A Minus: Outlook: Stable)	CARE "A- : Stable" (Single A Minus: Outlook: Stable)	Reaffirmed
Long - term / Short - term Bank Facilities	CARE "A- : Stable" / CARE "A2" (Single A Minus: Outlook: Stable/ A Two)	CARE "A- : Stable" / CARE "A2" (Single A Minus: Outlook: Stable/ A Two)	Reaffirmed
Short - term Bank Facilities	CARE "A2" (A Two)	CARE "A2" (A Two)	Reaffirmed

Kindly take note of the same and consider in your records.

Sincerely, For, Hester Biosciences Limited Rajiv Gandhi CEO & Managing Director DIN: 00438037